期刊
PUBLIC HEALTH GENOMICS
卷 13, 期 6, 页码 378-384出版社
KARGER
DOI: 10.1159/000319473
关键词
Personalized medicine; Research ethics
资金
- Richard M. Fairbanks Foundation, Indianapolis
- NCRR/NIH: Indiana Clinical and Translational Sciences Institute [UL1RR025761-01]
- Institute for Advanced Studies, Professor at Large Program, University of Western Australia
- National Human Genome Research Institute [P50 HG003389]
- NIH [U54 RR024374-01A1]
- NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER
With the completed sequence of the human genome has come the prospect of substantially improving the quality of life for millions through personalized medicine approaches. Still, any advances in this direction require research involving human subjects. For decades science and ethics have enjoyed an allegiance reflected in a common set of ethical principles and procedures guiding the conduct of research with human subjects. Some of these principles emphasize avoiding harm over maximizing benefit. In this paper we revisit the priority given to these ethical principles - particularly the principles that support a cautious approach to science - and propose a reframing of the 'social contract' between science and society that emphasizes reciprocity and meeting public needs. Copyright (C) 2010 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据